ClinicalTrials.Veeva

Menu

Localized Analysis of Normalized Distance From Scalp to Cortex and Personalized Evaluation (LANDSCAPE)

The Chinese University of Hong Kong logo

The Chinese University of Hong Kong

Status

Invitation-only

Conditions

Aging
Dementia Frontotemporal
Parkinson Disease
Depression in Old Age
Dementia Alzheimers

Treatments

Device: Transcranial Magnetic Stimulation

Study type

Observational

Funder types

Other

Identifiers

NCT05967390
2018.077 (Other Identifier)

Details and patient eligibility

About

Scalp to cortex distance (SCD), as a key technological parameter of brain stimulation, has been highlighted in the guidelines of non-invasive brain stimulation. However, in the context of age-related brain changes, the region-specific SCD and its impact on stimulation-induced electric field in different types of neurodegenerative diseases remain unclear.

Full description

Objective: This study aimed to investigate the region-specific SCD and its relationship with morphometric features and cognitive function in age- and disease-specific populations. Methods: The SCD and cortical thickness (CT) of left primary motor cortex (M1) and dorsolateral prefrontal cortex (DLPFC) were measured in cognitively normal adults and dementia patients. CT-adjusted SCD was used to control the influence of CT on SCD. Head model was developed to simulate the impact of SCD on the electric field induced by transcranial electrical stimulation.

Enrollment

488 estimated patients

Sex

All

Ages

60 to 95 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Right-handed as assessed by the Edinburgh Inventory
  • Able to attend TMS interventions
  • Consent
  • Independent in daily life activities

Exclusion criteria

  • Uncorrected visual or auditive deficits not allowing the realization of the test
  • Evolutive disease (such as cancer)
  • Neurological or psychiatric antecedent
  • Counter-indication to MRI

Trial design

488 participants in 1 patient group

Neurocognitive disorder (NCD)
Description:
The NCD patients are defined with a chronological age over 60 years and a Montreal Cognitive Assessment (MoCA) total score between 22 and 26.
Treatment:
Device: Transcranial Magnetic Stimulation

Trial contacts and locations

1

Loading...

Central trial contact

Shu Yang; Hanna LU, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems